UP!

TTPH $2.2

TTPH target price
2.20
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q1 2020 2020-05-06 0.00 0.00
Q4 2019 2020-03-12 -1.15 -2.75
Q3 2019 2019-11-12 -6.00 -6.00
Q2 2019 2019-08-08 -8.40 -8.40
Q1 2019 2019-05-08 -7.20 -7.20
Q4 2018 2019-03-14 -8.00 -8.00
Q3 2018 2018-11-08 -7.40 -7.40

Ratings

2016-06-20 Reiterated Rating Wedbush Neutral $4.00
2016-05-16 Reiterated Rating Gabelli Neutral
2016-05-14 Reiterated Rating Wedbush Buy
2016-05-14 Reiterated Rating Needham & Company LLC Hold
2016-05-13 Downgrade Gabelli Buy to Hold $7.00
2016-05-13 Lower Price Target Wedbush Outperform $8.00 to $4.00
2016-05-05 Reiterated Rating Wedbush Neutral $8.00 to $11.00
2016-04-11 Initiated Coverage BMO Capital Markets Market Perform $8.00
2016-02-24 Reiterated Rating Wedbush Neutral $11.00
2015-11-19 Upgrade SunTrust Neutral to Buy $12.00 to $21.00
2015-11-19 Upgrade SunTrust Banks Inc. Neutral to Buy $12.00 to $21.00
2015-11-18 Reiterated Rating Needham & Company LLC Hold
2015-11-17 Reiterated Rating Wedbush Neutral $11.00
2015-11-02 Reiterated Rating Needham & Company LLC Hold
2015-09-09 Downgrade SunTrust Buy to Neutral $54.00 to $12.00
2015-09-09 Lower Price Target Guggenheim Buy $60.00 to $20.00
2015-09-09 Downgrade Wedbush Outperform to Neutral $11.00
2015-09-09 Downgrade Robert W. Baird Outperform to Neutral $41.00 to $10.00
2015-09-09 Downgrade Needham & Company LLC Buy to Hold
2015-09-09 Downgrade Cantor Fitzgerald Buy to Hold $50.00 to $11.00
2015-09-09 Downgrade Nomura Buy to Neutral $54.00 to $10.00
2015-09-09 Downgrade Stifel Nicolaus Buy to Hold $57.00
2015-09-09 Downgrade Brean Capital Buy to Hold
2015-09-09 Downgrade JMP Securities Outperform to Market Perform
2015-09-09 Downgrade Nomura Holdings Inc. Buy to Neutral $54.00 to $10.00
2015-08-07 Reiterated Rating Cantor Fitzgerald Buy $50.00
2015-08-06 Reiterated Rating Stifel Nicolaus Buy $54.00 to $57.00
2015-08-06 Boost Price Target Needham & Company LLC Buy $46.00 to $56.00
2015-08-06 Boost Price Target Brean Capital Buy $50.00 to $51.00
2015-07-16 Boost Price Target Guggenheim Buy $45.00 to $60.00
2015-06-26 Boost Price Target Cantor Fitzgerald Buy $46.00 to $50.00
2015-06-18 Reiterated Rating SunTrust Buy $48.00
2015-05-07 Reiterated Rating Needham & Company LLC Buy $46.00
2015-05-06 Reiterated Rating Cantor Fitzgerald Buy $46.00
2015-04-27 Set Price Target Brean Capital Buy $50.00
2015-03-23 Initiated Coverage SunTrust Buy $48.00
2015-03-23 Initiated Coverage Nomura Buy $54.00
2015-03-06 Set Price Target Brean Capital Buy $50.00
2015-03-06 Boost Price Target Cantor Fitzgerald Buy $40.00 to $46.00
2014-12-18 Reiterated Rating Robert W. Baird Buy $41.00
2014-12-18 Reiterated Rating Wedbush Buy $51.00
2014-12-18 Boost Price Target Needham & Company LLC Buy $28.00 to $46.00
2014-12-18 Boost Price Target Cantor Fitzgerald BUY $26.00 to $40.00
2014-12-18 Boost Price Target Stifel Nicolaus Buy $28.00 to $54.00
2014-12-18 Boost Price Target Guggenheim $45.00
2014-12-18 Boost Price Target Brean Capital Buy $23.00 to $50.00
2014-11-04 Initiated Coverage Wedbush Outperform $31.00
2014-10-07 Reiterated Needham Buy $17 to $28
2014-10-07 Boost Price Target Needham & Company LLC Buy $17.00 to $28.00
2014-10-07 Boost Price Target Stifel Nicolaus Buy $21.00 to $28.00
2014-09-30 Boost Price Target JMP Securities Outperform $20.00 to $32.00
2014-09-08 Initiated Coverage Cantor Fitzgerald Buy $22.00
2014-09-03 Boost Price Target JMP Securities Outperform $16.00 to $20.00
2014-07-08 Initiated Coverage Brean Capital Buy $23.00
2014-06-20 Initiated Coverage Gabelli Buy
2014-06-17 Initiated Robert W. Baird Outperform $21
2014-06-16 Initiated Coverage Robert W. Baird Outperform $21.00
2014-06-02 Upgrade WBB Securities Speculative Buy to Buy $13.50 to $16.00
2014-04-04 Initiated Brean Capital Buy $23
2014-04-03 Initiated Coverage Brean Capital Buy $23.00
2014-03-06 Boost Price Target Needham & Company LLC Buy $15.00 to $17.00
2014-01-10 Boost Price Target Barclays Overweight $16.00 to $17.00
2013-11-13 Initiated Coverage Guggenheim Buy $25.00
2013-10-02 Boost Price Target Ladenburg Thalmann Buy $13.00 to $15.00
2013-10-01 Boost Price Target JMP Securities Market Outperform $12.00 to $16.00
2013-10-01 Reiterated Rating Needham & Company LLC Buy $12.00 to $15.00
2013-09-30 Initiated Coverage WBB Securities Speculative Buy
2016-06-20 Reiterated Rating Wedbush Neutral $4.00
2016-05-16 Reiterated Rating Gabelli Neutral
2016-05-14 Reiterated Rating Wedbush Buy
2016-05-14 Reiterated Rating Needham & Company LLC Hold
2016-05-13 Downgrade Gabelli Buy to Hold $7.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
EXCEL MEDICAL FUND LP 5.66%  (1468505) TTPH /
Flagship Ventures Fund 2004 L P 4.49%  (1165786) BIND / CNCE / TTOO / TTPH /
MEDIPHASE VENTURE PARTNERS II LP 2.08%  (540592) TTPH /
Macdonald Guy President and Chief Executive 0.50%  (129006) SCYX / TTPH /
Lubner David Charles SVP and CFO 0.27%  (69270) TTPH /
Trias Joaquim 0.20%  (52569) TTPH /
CMEA VENTURES VI LP 0.18%  (47992) IMI / TTPH /
GAGE L PATRICK 0.15%  (38880) CYTK / PDLI / TTPH /
Gullans Steven R. Ph.D. 0.10%  (25000) TTPH /
Sutcliffe Joyce A. Senior Vice President, Biology 0.07%  (17242) TTPH /
Horn Patrick Taylor Chief Medical Officer 0.04%  (10000) TTPH /
Xiao Xiao-Yi 0.03%  (9033) TTPH /
Dumas Jacques Chief ScientificOfficer 0.03%  (8750) IDIX / TTPH /
Freund John Gordon 0.02%  (6012) CNCE / MAKO / PRTO / TTPH / XNPT /
Skyline Venture Partners Qualified Purchaser Fund IV L P 0.02%  (4493) ABIO / ACRX / CNCE / TTPH /
Stahl Maria D SVP and General Counsel 0.01%  (2500) IDIX / TTPH /